FCT
ACAD icon

First Community Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

First Community Trust’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$1K – 303
2022
Q2 		$1K Hold
100
– – ﹤0.01% 351
2022
Q1 		$2K Hold
100
– – ﹤0.01% 351
2021
Q4 		$2.33K Buy
+100
New +$2.01K ﹤0.01% 353

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Community Trust's ACAD Position: Q3 2022 in Review

First Community Trust sold out of Acadia Pharmaceuticals (ACAD) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

First Community Trust first reported a position in ACAD in Q4 2021 and held it in 3 quarters. The position peaked at $2.33K in Q4 2021. 223 funds tracked by Wall St. Rank hold ACAD as of Q3 2022.

  • First Community Trust reported no remaining Acadia Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • First Community Trust sold 100 Acadia Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • First Community Trust first reported a position in Acadia Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • First Community Trust's Acadia Pharmaceuticals position peaked at $2.33K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2022.

Based on First Community Trust's 13F filing for Q3 2022, filed 14 Oct 2022.